A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment

A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment

Donor lymphocyte infusion (DLI) is used to prevent or treat haematological malignancies relapse after allogeneic stem cell transplantation (allo-SCT). Recombinant human granulocyte colony-stimulated factor primed DLI (gDLI) is derived from frozen aliquots of the peripheral blood stem cell collection...

Full description

Bibliographic Details
Main Authors: Sylvain Lamure, Franciane Paul, Anne-Laure Gagez, Jérémy Delage, Laure Vincent, Nathalie Fegueux, Anne Sirvent, Eve Gehlkopf, Jean Luc Veyrune, Lu Zhao Yang, Tarik Kanouni, Valère Cacheux, Jérôme Moreaux, Beatrice Bonafoux, Guillaume Cartron, John De Vos, Patrice Ceballos
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Journal of Clinical Medicine
Subjects:
Donor Lymphocyte Infusion, Allogeneic Stem Cell Transplantation, Post-transplant Treatment
Online Access:https://www.mdpi.com/2077-0383/9/7/2204

Internet

https://www.mdpi.com/2077-0383/9/7/2204

Similar Items